Oftaquix (Levofloxacin Hemihydrate)

Levofloxacin, the active ingredient in Oftaquix, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections in adults and children when indicated by a healthcare professional.

GNH USA supplies Oftaquix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftaquix, a fluoroquinolone antibiotic, is indicated for several bacterial infections affecting different organ systems.

- Community‑acquired bacterial pneumonia: eradicates susceptible respiratory pathogens and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and bacterial load. - Uncomplicated urinary tract infection: clears uropathogens and resolves symptoms. - Skin and soft‑tissue infections: treats susceptible Gram‑positive and Gram‑negative bacteria. - Acute exacerbation of chronic bronchitis: controls bacterial proliferation and aids recovery.

Levofloxacin may cause a range of adverse reactions, from mild to severe. Awareness of these effects helps clinicians monitor patients appropriately.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: often self‑limiting. - Headache: transient and usually resolves. - Dizziness: may affect balance. - Abdominal pain: discomfort in the stomach area. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis or angioedema. - Clostridioides difficile infection: colitis with watery diarrhea. - Peripheral neuropathy: sensory disturbances. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

Levofloxacin requires careful patient assessment and monitoring to minimize risks.

- Renal impairment: dose adjustment may be necessary based on kidney function. - History of tendon disorders: avoid use or monitor closely for tendon pain. - QT prolongation risk: obtain baseline ECG and monitor cardiac rhythm. - Pregnancy and lactation: prescribe only if benefits outweigh potential fetal or infant risks. - Concomitant medications: review for interactions that may increase toxicity. - Store at room temperature: keep in original container, protect from moisture and light.

Levofloxacin can alter the activity of several co‑administered drugs, necessitating vigilance.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Theophylline: elevated serum theophylline levels can cause toxicity. - Cyclosporine: increased risk of nephrotoxicity. - NSAIDs: heightened risk of central nervous system stimulation.

Moderate Interactions (Monitor Closely): - Ciprofloxacin: additive QT‑prolongation potential. - Rifampin: may lower levofloxacin plasma concentrations. - Diabetes medications (insulin, sulfonylureas): possible alterations in glucose control.